| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w20548 |
| 来源ID | Working Paper 20548 |
| The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India | |
| Mark Duggan; Craig Garthwaite; Aparajita Goyal | |
| 发表日期 | 2014-10-06 |
| 出版年 | 2014 |
| 语种 | 英语 |
| 摘要 | In 2005, as the result of a World Trade Organization mandate, India began to implement product patents for pharmaceuticals that were compliant with the 1995 Trade-Related Aspects of Intellectual Property Rights (TRIPS). We combine pharmaceutical product sales data for India with a newly gathered dataset of molecule-linked patents issued by the Indian patent office. Exploiting variation in the timing of patent decisions, we estimate that a molecule receiving a patent experienced an average price increase of just 3-6 percent with larger increases for more recently developed molecules and for those produced by just one firm when the patent system began. Our results also show little impact on quantities sold or on the number of pharmaceutical firms operating in the market. |
| 主题 | Health, Education, and Welfare ; Health ; Industrial Organization ; Market Structure and Firm Performance ; Development and Growth ; Innovation and R& ; D |
| URL | https://www.nber.org/papers/w20548 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/578222 |
| 推荐引用方式 GB/T 7714 | Mark Duggan,Craig Garthwaite,Aparajita Goyal. The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India. 2014. |
| 条目包含的文件 | 条目无相关文件。 | |||||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
